Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Global X Uranium ETF (URA)

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/05/2010

Market Cap

3,169,695,276

Shares Outstanding

91,530,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

URNM --.--%

UEC --.--%

CCJ --.--%

UUUU --.--%

COPX --.--%

Beta

0.8600

Last Div

1.7066

Range

21.69-33.66

Chg

-0.1950

Avg Vol

3117582

Mkt Cap

3169695276

Exch

AMEX

Country

US

Phone

NA

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0674

P/S

N/A

EV Multiple

N/A

P/FV

N/A

Div Yield %

6.7413

P/E

N/A

PEG

N/A

Payout

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash Ratio

N/A

DSO

N/A

DIO

N/A

Op Cycle

N/A

DPO

N/A

CCC

N/A

Gross Margin

N/A

Op Margin

N/A

Pretax Margin

N/A

Net Margin

N/A

Eff Tax Rate

N/A

ROA

N/A

ROE

N/A

ROCE

N/A

NI/EBT

N/A

EBT/EBIT

N/A

EBIT/Rev

N/A

Debt Ratio

N/A

D/E

N/A

LT Debt/Cap

N/A

Total Debt/Cap

N/A

Int Coverage

N/A

CF/Debt

N/A

Equity Multi

N/A

Rec Turnover

N/A

Pay Turnover

N/A

Inv Turnover

N/A

FA Turnover

N/A

Asset Turnover

N/A

OCF/Share

N/A

FCF/Share

N/A

Cash/Share

N/A

OCF/Sales

N/A

FCF/OCF

N/A

CF Coverage

N/A

ST Coverage

N/A

CapEx Coverage

N/A

Div&CapEx Cov

N/A

P/BV

N/A

P/B

N/A

P/S

N/A

P/E

N/A

P/FCF

N/A

P/OCF

N/A

P/CF

N/A

PEG

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

DPS

1.7066

Latest Headlines (EST)

GlobeNewswire Inc. Jun 01, 23:00 Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML Benzinga Dec 12, 22:19 SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kineta, Inc. - KANT GlobeNewswire Inc. Sep 30, 22:30 Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology MarketWatch Jan 18, 15:23 China-focused ETFs struggle amid fears of another regulatory ‘crackdown’ MarketWatch Jan 13, 05:30 What history says about first-of-a-kind ETFs as bitcoin products debut Seeking Alpha Jan 13, 00:17 URA: Betting On Uranium Demand When Global Supply Is In Peril Seeking Alpha Jan 13, 00:17 URA: Betting On Uranium Demand When Global Supply Is In Peril MarketWatch Jan 12, 12:26 What history says about first-of-a-kind ETFs as bitcoin products debut MarketWatch Jan 12, 12:26 What history says about first-of-a-kind ETFs as bitcoin products debut MarketWatch Jan 11, 18:07 What history says about first-of-a-kind ETFs as bitcoin products debut Seeking Alpha Jan 11, 00:33 Uranium Miners Breaking Out (Technical Analysis) Seeking Alpha Jan 11, 00:33 Uranium Miners Breaking Out (Technical Analysis) Benzinga Dec 22, 12:50 Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst Benzinga Dec 22, 12:50 Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst GlobeNewswire Inc. Dec 08, 07:30 Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial MarketWatch Nov 30, 12:18 What ETF investors need to know before adding gold to their portfolios GlobeNewswire Inc. Nov 28, 07:30 Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit Benzinga Nov 17, 13:01 Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session GlobeNewswire Inc. Nov 02, 07:30 Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC GlobeNewswire Inc. Oct 30, 07:30 Kura Oncology to Participate in Three Upcoming Investor Conferences

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.02 06/27/2024 12/28/2023 06/27/2024 07/05/2024
1.68 12/28/2023 01/11/2023 12/29/2023 01/08/2024
0.05 12/29/2022 02/01/2022 12/30/2022 01/09/2023
0.10 06/29/2022 02/01/2022 06/30/2022 07/08/2022
1.31 12/30/2021 12/29/2021 12/31/2021 01/07/2022
0.02 06/29/2021 01/07/2021 06/30/2021 07/08/2021
0.10 12/30/2020 01/20/2020 12/31/2020 01/08/2021
0.16 06/29/2020 01/20/2020 06/30/2020 07/08/2020
0.08 12/30/2019 01/21/2019 12/31/2019 01/08/2020
0.10 06/27/2019 01/21/2019 06/28/2019 07/08/2019
0.05 12/28/2018 01/27/2018 12/31/2018 01/08/2019
0.31 12/28/2017 12/27/2017 12/29/2017 01/09/2018
0.94 12/28/2016 11/30/-0001 12/30/2016 01/06/2017
0.27 12/29/2015 11/30/-0001 12/31/2015 01/08/2016
0.49 12/29/2014 11/30/-0001 12/31/2014 01/08/2015
0.08 12/27/2013 11/30/-0001 12/31/2013 01/08/2014
0.12 12/27/2012 11/30/-0001 12/31/2012 01/09/2013
0.39 12/29/2010 11/30/-0001 11/30/-0001 11/30/-0001